<table border="0" cellpadding="0" cellspacing="0" id="i27388b4b-bdb7-4b55-8bfb-235a0e6b755c" width="489" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>
                Table 2: Pharmacokinetic Parameters of Stavudine in HIV-Infected
                Adults: Bioavailability, Distribution, and Clearance
              </caption>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th>Parameter </th>
<th> Mean ± SD   </th>
<th>   n   </th>
</tr>
</thead>
<tbody>
<tr>
<td>
<sup>a</sup> following 1-hour IV infusion.<br/>
<sup>b</sup> following single oral dose.<br/>
<sup>c</sup>
                    assuming a body weight of 70 kg.<br/>
<sup>d</sup> over 12 to 24
                    hours.<br/>
</td>
</tr>
</tbody>
<tbody>
<tr>
<td>
                    Oral bioavailability (%)<br/>  <br/> Volume of
                    distribution (L)<sup>a</sup>
<br/>  <br/> Total body clearance
                    (mL/min)<sup>a</sup>
<br/>  <br/> Apparent oral clearance
                    (mL/min)<sup>b</sup>
<br/>  <br/> Renal clearance (mL/min)<sup>a</sup>
<br/>  <br/> Elimination half-life, IV dose (h)<sup>a</sup>
<br/>  <br/> Elimination half-life, oral dose (h)<sup>b</sup>
<br/>  <br/> Urinary recovery of stavudine (% of dose)<sup>a,d  </sup>
<br/>
</td>
<td>
                    86.4 ± 18.2<br/>  <br/>46 ± 21 <br/> 
                    <br/>594 ± 164 <br/>  <br/>560 ± 182<sup>c</sup>
<br/>  <br/>237 ± 98
                    <br/>  <br/>1.15 ± 0.35 <br/>  <br/>1.6 ± 0.23<br/>  <br/>42 ± 14 <br/>
</td>
<td>
                    25   <br/>  <br/>   44   <br/> 
                    <br/>   44   <br/>  <br/>    113     <br/>  <br/>   39   <br/>  <br/>   44   <br/> 
                    <br/>   8   <br/>  <br/>   39   <br/>
</td>
</tr>
</tbody>
</table>